Medicaid Expansion and Healthcare Workers; Cardiac Rehabilitation
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 2, 2024 Category: Allergy & Immunology Source Type: news

Epinephrine Nasal Spray Starts Reversing Allergic Reactions in Minutes
(MedPage Today) -- WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and teenagers undergoing an... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 2, 2024 Category: Allergy & Immunology Source Type: news

What's Changed in Asthma Treatment? Quite a Bit What's Changed in Asthma Treatment? Quite a Bit
For primary care, Dr Neil Skolnik highlights the essential asthma treatment changes in the latest GINA guidelines, and the four questions to ask to assess asthma control.Medscape Family Medicine (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 1, 2024 Category: Allergy & Immunology Tags: Family Medicine/Primary Care Commentary Source Type: news

Peanut Allergen Sensitization Seen in Younger Siblings of LEAP Study Participants
(MedPage Today) -- WASHINGTON -- Among the younger siblings of children who consumed peanut allergens as part of the LEAP trial, there was a trend toward peanut sensitization, though this effect was reduced if peanut was introduced early, results... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 1, 2024 Category: Allergy & Immunology Source Type: news

Puzzling skin side effects stymie advance of promising HIV vaccine
One of the most promising attempts to reinvigorate the stalled quest for an HIV vaccine has hit a snag that might seem minor but has major consequences: delaying the larger trials needed to show whether the concept works. In small safety and immune tests of the innovative vaccine strategy, which relies on a series of messenger RNA (mRNA) shots, an unusually high percentage of recipients developed rashes, welts, or other skin irritations. “We are taking this very seriously,” says Carl Dieffenbach, who heads the Division of AIDS at the National Institute of Allergy and Infectious Diseases, which funded a recent pha...
Source: ScienceNOW - March 1, 2024 Category: Science Source Type: news

AAAAI 2024: Insights on Advancements in Food Allergy Management AAAAI 2024: Insights on Advancements in Food Allergy Management
Dr David A. Hill shares highlights from AAAAI 2024, including the new indication for omalizumab and fresh data on oral immunotherapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2024 Category: Consumer Health News Tags: Allergy & Clinical Immunology MDAngle Source Type: news

Oral Transmission of Chagas Disease Has Severe Effects Oral Transmission of Chagas Disease Has Severe Effects
Unlike vector transmission, oral transmission of Chagas disease entails high lethality in pediatric and adult populations.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 1, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news

Generic SpA Screening Tool Needed Across Comorbid Diseases Generic SpA Screening Tool Needed Across Comorbid Diseases
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients with uveitis or IBD, compared with psoriasis.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 1, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news

Review Highlights Evidence of Climate Change Effects on AD Review Highlights Evidence of Climate Change Effects on AD
Atopic dermatitis " could serve as a case study for climatic impacts on health, " the authors emphasized in their paper.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 1, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

Indoor Pest Exposures Tied to Respiratory Issues in Kids With Asthma
(MedPage Today) -- WASHINGTON -- Among kids with asthma, indoor allergen exposure to pests like mice and cockroaches was associated with occurrence of upper respiratory infections (URIs), according to a longitudinal study. Among 90 mostly Black... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 1, 2024 Category: Allergy & Immunology Source Type: news

Doctor's Family Sues Disney Over Food Allergy Death; Doctor Skipped Payroll Taxes?
(MedPage Today) -- The family of New York doctor Kanokporn Tangsuan, DO, is suing Disney following her death, allegedly from eating a meal that wasn't allergen-free. Tangsuan was highly allergic to nuts and dairy and reportedly died from anaphylaxis... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 29, 2024 Category: American Health Source Type: news

Getting Unfair Patient Reviews? These Apps Promise Relief Getting Unfair Patient Reviews? These Apps Promise Relief
Negative patient reviews can wound your practice. Could automated systems that ask satisfied patients to leave reviews offer help?Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 29, 2024 Category: Allergy & Immunology Tags: Family Medicine/Primary Care Source Type: news

Omalizumab for Food Allergies: What PCPs Should Know Omalizumab for Food Allergies: What PCPs Should Know
With omalizumab recently approved to treat multiple food allergies, allergist-immunologists advised PCPs on how they can use the drug in practice.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 29, 2024 Category: Allergy & Immunology Tags: Internal Medicine Source Type: news

FDA Approves Omalizumab for Multiple Food Allergy FDA Approves Omalizumab for Multiple Food Allergy
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 29, 2024 Category: Allergy & Immunology Tags: Emergency Medicine Source Type: news

Novel Antibody for Chronic Hives Brings Relief in Mid-Stage Trial
(MedPage Today) -- WASHINGTON -- Barzolvolimab, a first-in-class anti-KIT monoclonal antibody, reduced the severity of hives in adults with chronic spontaneous urticaria (CSU) who remained symptomatic on antihistamines, a randomized phase II... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 29, 2024 Category: Allergy & Immunology Source Type: news